All posts in Neuro
OrthoNeuro Technologies Announces an Exclusive Partnership with Southern California University of Health Sciences
OrthoNeuro Technologies, Inc. (http://www.ortho-neuro.com), a technology company that designs and integrates products and services focused on technique skills development to increase proficiency in the Spinal Care Professional community, announces an exclusive partnership to provide the Dynadjust Spinal Manipulation Training System ...
InVivo Therapeutics Co-Founder Dr. Robert S. Langer Awarded Annual Innovation Award from The Economist
CAMBRIDGE, Mass., Dec 12, 2011 (BUSINESS WIRE) -- InVivo Therapeutics Holdings Corp. (otc/bb:NVIV), a company focused on the development of groundbreaking technologies for the treatment of spinal
Spinal Modulation System Receives CE Mark for the Management of Chronic Intractable Pain
LAS VEGAS, Dec 08, 2011 (BUSINESS WIRE) -- Spinal Modulation, a privately held global medical device company, announced today that the Spinal Modulation Neurostimulator System has received
Paralyzed man stands, steps after spine treatment
NEW YORK (Reuters) – A man left paralyzed after a car accident was able to stand and take steps after electrical stimulation of his spinal cord in what
NeoStem Announces Agreement With Shijiazhuang Third Hospital in the Provincial Capital of Hebei Province, China to Offer Orthopedic Applications Based on NeoStem’s Licensed Technology
NEW YORK, Dec. 9, 2010 /PRNewswire/ -- NeoStem, Inc. (NYSE Amex: NBS) ("NeoStem" or the "Company"), an international biopharmaceutical company with product and service revenues, global research and
InVivo exceeds private placement by $2.5M
InVivo Therapeutics today said that its previously announced $10.5 million private placement actually brought in $13 milion with additional units being purchased by Spencer Trask Ventures Inc., which
Vycor Medical Announces Acquisition of Therapeutic and Diagnostic Vision Restoration Company — NovaVision
BOHEMIA, NY, Nov 12, 2010 (MARKETWIRE via COMTEX) -- Vycor Medical, Inc. (OTCBB: VYCO | PowerRating) (www.vycormedical.com), a medical device company that designs, develops and markets
InVivo Therapeutics opens Medford facility
InVivo Therapeutics Corp., a life sciences company developing technologies for the treatment of spinal cord injuries, has signed a lease to open its first manufacturing and development facility
Neuralstem Awarded Three Federal Grants
ROCKVILLE, Md., Nov. 2, 2010 /PRNewswire/ -- Neuralstem, Inc. (NYSE Amex: CUR) announced that it has been awarded three Federal grants, totaling $733,438 through the Patient Protection and Affordable Care
Zynex Announces New Chief Financial Officer
LITTLETON, Colo.--(BUSINESS WIRE)--Zynex, Inc. (OTCBB: ZYXI), a provider of pain management systems and electrotherapy products for medical patients with functional disability, announces that Anthony Scalese has
Stryker Said to Be in Talks on Boston Scientific Unit
Aug. 17 (Bloomberg) -- Stryker Corp., a maker of artificial hips and knees, is in advanced talks to buy Boston Scientific Corp.’s pain-management device unit for about $1.5
J&J Buying Stroke-Treatment Co Micrus For $480M
Johnson & Johnson (JNJ) said Monday it plans to bolster its lineup of stroke-prevention products by buying Micrus Endovascular Corp. (MEND) for about $480 million, marking the latest
Medtronic Launches Award-Winning Neuro Oncology Surgical Imaging System in the United States
MINNEAPOLIS--(BUSINESS WIRE)--Medtronic (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) 510(K) clearance and U.S. launch of the PoleStar® N30 Surgical MRI system, the latest in
Axerion gets $750,000 for neuro research
Connecticut Innovations today said it has invested $750,000 in New Haven-based Axerion Therapeutics Inc., a Yale University spinoff that is developing treatments for neurological injuries and diseases. Axerion was
Acorda Therapeutics Announces Filing of Patent Extension Applications for AMPYRA(TM) (dalfampridine)
HAWTHORNE, N.Y., Mar 22, 2010 (BUSINESS WIRE) -- Acorda Therapeutics, Inc. (ACOR 34.95, +0.11, +0.32%)today announced that the Company has submitted applications to extend patent protection for